For more information about product availability globally, please click below.

OrbusNeich Medical Co. Ltd.:

→APAC (Asia-Pacific)
→EMEA (Europe, Middle East, Africa)

In July 2018, Cardiovascular Systems, Inc. (CSI®) announced that OrbusNeich Medical Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems outside the United States and Japan.

Medikit Co., Ltd:

→Japan

In November 2016, Cardiovascular Systems, Inc. (CSI®) announced that Medikit, Co., Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Japan.

PT. Revass Utama Medika:

→Indonesia

In  February 2021, Cardiovascular Systems, Inc. (CSI®) announced that PT. Revass Utama Medika signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Indonesia.

Bio-Excel (Australia) Pty. Ltd.:

→Australia

In March 2021, Cardiovascular Systems, Inc. (CSI®) announced that Bio-Excel Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Australia.

Smart Solutions that advance treatment for complex patients

At CSI, weare a culture of innovation.
We observe carefully, listen closely and collaborate extensively,
seeking opportunities to help interventionalists do their jobs more easily and more effectively –
all with the goal of improving patient care.

 

CLICK HERE to Learn More About CSI's Innovations